Metraipolis › archive › dc_3cb8a26e7caf
Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants — Europe PMC PMID:41820555
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41820555
- DOI
- 10.1038/s41564-[numero omesso]-x
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-04T11:09:32.527Z
- SHA-256 of the archived text
dfe5a1ddf448262b8df07bbcebe08fe34f932e411a18cd4ed1ba60cdc9985951- Stable URL of this page
https://metraipolis.com/documento/dc_3cb8a26e7caf
How to cite
Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants — Europe PMC PMID:41820555 — Europe PMC (en), https://europepmc.org/article/MED/41820555 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3cb8a26e7caf (Metraipolis archive dc_3cb8a26e7caf, sha256 dfe5a1ddf448262b8df07bbcebe08fe34f932e411a18cd4ed1ba60cdc9985951)
BibTeX
@misc{dc3cb8a26e7caf,
title = {Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants — Europe PMC PMID:41820555},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41820555},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3cb8a26e7caf; sha256 dfe5a1ddf448262b8df07bbcebe08fe34f932e411a18cd4ed1ba60cdc9985951},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41820555. Agents can read the archived copy with the MCP tool read_document.